Biopharmaceutical Company Rebranded as Stablecoin Development Corporation
The corporate pivot playbook that Strategy wrote for Bitcoin is being applied to the stablecoin economy. A pharmaceutical company with under $10 million in annual revenue just became one of the largest holders of a stablecoin governance token.
BTC
Disclaimer: This content is provided via CryptoPanic and third-party sources. Tothemoon does not create, verify, or endorse this content and makes no guarantees as to its accuracy. The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. It is provided for informational purposes only and is not investment advice.
